Description

Warfarin Sodium IP 1 mg is an anticoagulant formulation developed for the prevention and management of thromboembolic disorders under medical supervision. The formulation is widely used to help reduce the risk of blood clot formation in patients with conditions that may increase the likelihood of stroke, deep vein thrombosis (DVT), pulmonary embolism, and other clot-related cardiovascular complications.

Blood clots play an important role in preventing excessive bleeding following injury. However, abnormal clot formation within blood vessels can restrict blood flow and lead to serious health conditions. Effective anticoagulant therapy is essential for patients at increased risk of clot formation, helping support healthy circulation and reducing the likelihood of potentially life-threatening complications.

Warfarin Sodium belongs to a class of medicines known as vitamin K antagonists. It works by reducing the production of specific clotting factors in the liver that are dependent on vitamin K. By slowing the blood clotting process, Warfarin helps prevent the formation and growth of harmful blood clots while maintaining appropriate circulation throughout the body.

The formulation is commonly prescribed for patients with atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism, and other conditions requiring long-term anticoagulant therapy. Regular monitoring of blood clotting parameters may be required to ensure optimal therapeutic outcomes and patient safety.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Effective anticoagulant formulation
• Supports prevention of harmful blood clot formation
• Helps maintain healthy blood circulation
• Supports long-term thromboembolic disorder management
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes

Uses

• Prevention of blood clot formation
• Deep vein thrombosis (DVT) management
• Pulmonary embolism management
• Stroke risk reduction in selected patients
• Anticoagulant therapy under medical supervision

How It Works

Warfarin Sodium works by inhibiting the action of vitamin K involved in the production of clotting factors. This action helps reduce the blood’s ability to form harmful clots and supports healthy circulation.

Possible Side Effects

Common side effects may include:

• Increased tendency to bleed
• Easy bruising
• Nosebleeds
• Gum bleeding
• Nausea
• Stomach discomfort
• Fatigue

Patients should seek immediate medical attention if severe bleeding, blood in urine or stools, unusual bruising, severe headache, or other serious symptoms occur.

Precautions

• Use only under strict medical supervision
• Regular blood clotting monitoring may be required
• Inform your doctor about all medications, supplements, and medical conditions
• Avoid activities that may increase the risk of injury or bleeding
• Do not alter dosage without medical advice

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to international pharmaceutical standards to maintain consistent quality and reliable patient outcomes.